UBS reiterated a Buy rating on Cardinal Health (NYSE: CAH), and raise the price target to $100.00 (from $97.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Leerink Partners Raises Price Target on Cardinal Health (CAH) Following Conference Call November 4, 2015 3:03 PM Pre-Open Stock Movers 11/02: (HTCH) (DYAX) (CTCT) Higher; (CMG) (CL) (V) Lower (more...)November 2, 2015 9:28 AM Cardinal Health (CAH) Tops Q1 EPS by 28cNovember 2, 2015 7:47 AM Cardinal Health Reports Strong First-Quarter Results For Fiscal 2016November 2, 2015 7:00 AM Trading Radar for 11/2: Visa (V), AIG (AIG), Fitbit (FIT), Clorox (CLX), Loews (L), Sysco (SYY) General Growth (GGP) ReportOctober 30, 2015 3:35 PM